Entrepreneurship, R&D, Maketing, Innovation
2.7K views | +0 today
Follow
Entrepreneurship, R&D, Maketing, Innovation
Entrepreneurship, R&D, Maketing, Innovation
Curated by Ari Massoudi
Your new post is loading...
Your new post is loading...
Scooped by Ari Massoudi
Scoop.it!

Le prochain saut évolutif de l'espèce humaine sera ...

Le prochain saut évolutif de l'espèce humaine sera ... | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Quel est selon vous, le prochain saut évolutif de l'espèce humaine ? L’auriculaire en moins, un 3ème œil derrière la tête, plus aucun poils du tout sur tout le corps ... ?
Avant de répondre à...
more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

To Cure Cancer, Provide a Profit Motive

To Cure Cancer, Provide a Profit Motive | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Creative investments could fund a huge number of new drug-development projects
more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

MediCortex Developing Therapeutic Drugs for Combat-Related Traumatic Brain Injury

MediCortex Developing Therapeutic Drugs for Combat-Related Traumatic Brain Injury | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
(PRWEB) March 23, 2014 -- MediCortex is currently conducting research and developing therapeutic drugs with the purpose of limiting the long-term neurodegenerative effects caused by TBI. The company seeks to assist combat veterans who have sustained brain damage on the battlefield.
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

MediCortex to Develop New Therapeutic Drugs for Sports-Related Traumatic Brain Injury (TBI)

MediCortex to Develop New Therapeutic Drugs for Sports-Related Traumatic Brain Injury (TBI) | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Pioneering research could revolutionize treatment of brain injuries in professional and amateur athletes Wilmington, Delaware and Ness-Ziona, Israel (MMD Newswire) February 07, 2014 - Every time
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world of people under 45 years-old.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Acid Shock Converts Adult Cells to Stem Cells!

Acid Shock Converts Adult Cells to Stem Cells! | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
External stresses, such as low pH, may reprogram mammalian somatic cells, resulting in the generation of pluripotent cells.
more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Dr. Adrian Harel Pursuing New Therapies for Traumatic Brain Injury (TBI) in Infants, Children and Young Adults

Dr. Adrian Harel Pursuing New Therapies for Traumatic Brain Injury (TBI) in Infants, Children and Young Adults | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
New research could provide new hope to young victims and their families Israel (Ness-Ziona) and US (Wilmington) (MMD Newswire) January 16, 2014 - - We've all been shocked and outraged by a news story
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world of people under 45 years-old.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Study Links Traumatic Brain Injury and Post-Traumatic Stress Disorder

Study Links Traumatic Brain Injury and Post-Traumatic Stress Disorder | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Traumatic brain injuries during deployments appear to increase the risk of troops experiencing post-traumatic stress disorder after returning home, according to Department of Veterans Affairs-sponsored research published Wednesday.
more...
No comment yet.
Rescooped by Ari Massoudi from Emerging Trends in Pharma and Biotech
Scoop.it!

The great neuro-pipeline ‘brain drain’ (and why Big Pharma hasn’t given up on CNS disorders)

The great neuro-pipeline ‘brain drain’ (and why Big Pharma hasn’t given up on CNS disorders) | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Central Nervous System (CNS) disorders bear an economic burden of more than $2 trillion in the US and EU and rake in upwards of $80 billion a year for the pharmaceutical industry. Yet they have become as much a vice as a potential virtue.

Via Bioassociate
Ari Massoudi's insight:

Bioassociate
Life science, biotech and pharma consulting with a twist from the heart of the world's Start-up Nation - Israel. Follow us for the coolest bio-developments!
http://www.bioassociate.com 

more...
Bioassociate's curator insight, December 31, 2013 12:52 PM

Bioassociate is on the cover of this fall's Drug Discovery World with an article discussing why Big Pharma no longer risks developing brain drugs 

Scooped by Ari Massoudi
Scoop.it!

MediCortex Wants to Knock-Out Traumatic Brain Injury!

MediCortex Wants to Knock-Out Traumatic Brain Injury! | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world of people under 45 years-old.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Encéphalopathie post-Traumatique Chronique : Véritable Epidémie !

Encéphalopathie post-Traumatique Chronique : Véritable Epidémie ! | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
(Photo de Jérome Le Banner, multiple Champion du Monde de Kick-Boxing) Une…
Ari Massoudi's insight:

The pharmaceutical startup company MediCortex focuses on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury which is a major risk of disability and death for professional boxers, American football, rugby or ice hockey players, but also war veteran soldiers, car accident victims ... .
Currently, there is no therapy or molecule (pharmaceutical drug) that can slow-down or stop the degeneration of brain tissue after Traumatic Brain Injury. The scientific approach of MediCortex to prevent the neurodegeneration after TBI, is novel and very promising.
http://www.medicortex.com/ ;

 

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Traumatisme cranio-cérébral: des chocs pour les neurones

Traumatisme cranio-cérébral: des chocs pour les neurones | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Information santé romande
Ari Massoudi's insight:

Medicortex USA Ltd. is a start-up pharmaceutical company focused on the discovery and pre-clinical development of innovative therapies for the treatment of acute neurodegenerative conditions, including Traumatic Brain Injury, exposure to toxic nerve agent and stroke. Medicortex’s mission is to develop a truly effective neuroprotection therapy that limits the damage in brain injury, based on a novel multifunctional drug approach.

http://www.medicortex.com/

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Medicortex CEO Dr. Adrian Harel will participate in the 22nd Israel Society for Neuroscience Annual Meeting

Medicortex CEO Dr. Adrian Harel will participate in the 22nd Israel Society for Neuroscience Annual Meeting | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Traumatic Brain Injury (TBI) is a frequent neurological condition, representing a worldwide economic burden with rapidly growing incidence.
Ari Massoudi's insight:

Medicortex USA Ltd. is a start-up pharmaceutical company focused on the discovery and pre-clinical development of innovative therapies for the treatment of acute neurodegenerative conditions, including Traumatic Brain Injury, exposure to toxic nerve agent and stroke. Medicortex’s mission is to develop a truly effective neuroprotection therapy that limits the damage in brain injury, based on a novel multifunctional drug approach.

http://www.medicortex.com/

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Researchers film early concussion damage, describe brain's response to injury (w/ Video)

Researchers film early concussion damage, describe brain's response to injury (w/ Video) | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
There is more than meets the eye following even a mild traumatic brain injury. While the brain may appear to be intact, new findings reported in Nature suggest that the brain's protective coverings may feel the brunt of the impact.
Ari Massoudi's insight:

The pharmaceutical startup company MediCortex focuses on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury which is a major risk of disability and death for professional boxers, American football, rugby or ice hockey players, but also war veteran soldiers, car accident victims ... .
Currently, there is no therapy or molecule (pharmaceutical drug) that can slow-down or stop the degeneration of brain tissue after Traumatic Brain Injury. The scientific approach of MediCortex to prevent the neurodegeneration after TBI, is novel and very promising.
http://www.medicortex.com/ ;

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

TPE: L'intérêt des cellules IPS dans la Progéria

TPE: L'intérêt des cellules IPS dans la Progéria | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Réalisé par Nicolas TRAUTWEIN, François LAVENU et Scott OSWALD
more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

New Approach from MediCortex - Developing Therapeutic Drugs for Combat-Related Traumatic Brain Injury

New Approach from MediCortex - Developing Therapeutic Drugs for Combat-Related Traumatic Brain Injury | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Press Release issued Mar 25, 2014: MediCortex, a start-up pharmaceutical company focused on the treatment of neurodegenerative conditions, is developing therapeutic drug which will limit the long-term effects of brain injury, including the types of severe brain trauma that veterans have received in combat.
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

MediCortex USA, Ltd. to present at the 8th annual BIO-Europe Spring conference, March 10-12, Turin Italy

MediCortex USA, Ltd. to present at the 8th annual BIO-Europe Spring conference, March 10-12, Turin Italy | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Dr. Adrian Harel, MediCortex’s founder and CEO, stated: “At this year's conference, me and Dr. Ari Massoudi will present the development plan of our new drug candidates, which are aimed at moderating the effects of TBI. The company has designed three chemically verified proprietary NCE’s, each with properties for crossing the brain-blood-barrier, and possessing at least two neuroprotective functions, such as free metal ion binding, anti-oxidation, anti-inflammation, and/or anti-bacterial activity.”
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause in the world of psychological disorders, disability and death.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

The Illustrated Guide To A Ph.D.

The Illustrated Guide To A Ph.D. | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
A Ph.D. is hard to describe it in words. So, here it is in pictures.
more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

MediCortex Pursuing New Therapies for Traumatic Brain Injury in Infants, Children and Young Adults

MediCortex Pursuing New Therapies for Traumatic Brain Injury in Infants, Children and Young Adults | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world of people under 45 years-old.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

ITW: Dr. Adrian Harel Researching New Drugs for Victims of Traumatic Brain Injury on the Brain Injury Radio

ITW: Dr. Adrian Harel Researching New Drugs for Victims of Traumatic Brain Injury on the Brain Injury Radio | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Dr. Adrian Harel, is owner and president of MediCortex, operating in Israel and the US.
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world of people under 45 years-old.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Head Games - Trailer

Head Games is a revealing documentary about the concussion crisis in sports. Athletes and parents share their personal struggles in dealing with concussions from…
more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Medicortex: Dr. Adrian Harel proposes a multi-functional drug approach for the treatment of Traumatic Brain Injury (TBI)

Medicortex: Dr. Adrian Harel proposes a multi-functional drug approach for the treatment of Traumatic Brain Injury (TBI) | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Research could lead to new drugs to halt or prevent secondary TBI Israel (Ness-Ziona) and US (Wilmington) (MMD Newswire) December 31, 2013 -- With the ever-more-frequent news reports of athletes'
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world of people under 45 years-old.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

MediCortex Veut Mettre KO l'Encéphalopathie Traumatique Chronique!

MediCortex Veut Mettre KO l'Encéphalopathie Traumatique Chronique! | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
MediCortex USA Ltd. : http://www.medicortex.com MediCortex est une start-up…
Ari Massoudi's insight:

MediCortex http://www.medicortex.com 

MediCortex is a pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury (TBI) which is the first cause of psychological disorders, disability and death in the world of people under 45 years-old.

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

League of Denial: The NFL’s Concussion Crisis

League of Denial: The NFL’s Concussion Crisis | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
FRONTLINE reveals the hidden story of the NFL and brain injuries.
Ari Massoudi's insight:

The pharmaceutical startup company MediCortex focuses on the discovery of innovative therapies for the treatment of the progressive neural tissue degeneration caused by Traumatic Brain Injury which is a major risk of disability and death for professional boxers, American football, rugby or ice hockey players, but also war veteran soldiers, car accident victims ... .
Currently, there is no therapy or molecule (pharmaceutical drug) that can slow-down or stop the degeneration of brain tissue after Traumatic Brain Injury. The scientific approach of MediCortex to prevent the neurodegeneration after TBI, is novel and very promising.
http://www.medicortex.com/ ;

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

Nonconcussion head impacts in contact sports linked to brain changes and lower test scores

Nonconcussion head impacts in contact sports linked to brain changes and lower test scores | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Repeated blows to the head during a season of contact sports may cause changes in the brain's white matter and affect cognitive abilities even if none of the impacts resulted in a concussion.
Ari Massoudi's insight:

Medicortex USA Ltd.: - http://www.medicortex.com/

Medicortex is pharmaceutical startup company focused on the discovery of innovative therapies for the treatment of brain degeneration caused by Traumatic Brain Injury which is a major risk of disability and death for professional boxers/fighters, American football, rugby or ice hockey players, but also veteran soldiers, car accident victims ... (1.5 million people die every year due to TBI complications).

more...
No comment yet.
Scooped by Ari Massoudi
Scoop.it!

BrainStorm Cell Therapeutics - December 10, 2013

BrainStorm Cell Therapeutics - December 10, 2013 | Entrepreneurship, R&D, Maketing, Innovation | Scoop.it
Autologous Stem Cell Therapy for neurodegenerative diseases such as ALS, using bone marrow-derived, neurotrophic factor-secreting mesenchymal stem cells.
Ari Massoudi's insight:

Preliminary Findings of BrainStorm's Phase IIa Study Reported as "Extremely Optimistic"

 

BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).


http://www.brainstorm-cell.com/

more...
No comment yet.